MCID: CRV002

Cervix Uteri Carcinoma in Situ malady

Summaries for Cervix Uteri Carcinoma in Situ

Sources:
22MalaCards
See all sources

Export this MalaCard
MalaCards: Cervix Uteri Carcinoma in Situ, also known as carcinoma in situ of uterine cervix, is related to adenocarcinoma in situ and hepatocellular carcinoma. An important gene associated with Cervix Uteri Carcinoma in Situ is MRFAP1 (Morf4 family associated protein 1), and among its related pathways are Platelet Aggregation Inhibitor Pathway, Pharmacodynamics and Blood Coagulation Signaling Pathways. The drugs carmustine and diethylstilbestrol diphosphate have been mentioned in the context of this disorder. Affiliated tissues include cervix.

Aliases & Descriptions for Cervix Uteri Carcinoma in Situ

Sources:
6Disease Ontology, 8DISEASES, 43UMLS, 40SNOMED-CT, 19ICD9CM, 24MeSH, 27NCIt
See all sources

Aliases & Descriptions:

cervix uteri carcinoma in situ 6 8
carcinoma in situ of uterine cervix 6 43
cervical intraepithelial neoplasia grade iii with severe dysplasia (disorder) 6
carcinoma in situ of uterine cervix (disorder) 6
squamous intraepithelial neoplasia, grade iii 6
carcinoma of cervix stage 0 (disorder) 6
cin iii - carcinoma in situ of cervix 6
severe dysplasia of the cervix uteri 6
cin iii - severe dyskaryosis 6
carcinoma in situ of cervix 6
severe dysplasia of cervix 6
intraepithelial neoplasia 43
malignant tumor of cervix 43
cervix ca in situ 6
cervix carcinoma 43
severe dysplasia 43
carcinoma 43
cin iii 6

Related Diseases for Cervix Uteri Carcinoma in Situ

Sources:
13GeneCards, 14GeneDecks
See all sources

Graphical network of the top 20 diseases related to cervix uteri carcinoma in situ:



Graphical network of diseases related to cervix uteri carcinoma in situ

Clinical Features for Cervix Uteri Carcinoma in Situ

Drugs & Therapeutics for Cervix Uteri Carcinoma in Situ

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for cervix uteri carcinoma in situ

Drug clinical trials:

Search ClinicalTrials for cervix uteri carcinoma in situ

Search NIH Clinical Center for cervix uteri carcinoma in situ

Search CenterWatch for cervix uteri carcinoma in situ

Inferred drug relations via UMLS/NDF-RT:

43 28 carmustine, diethylstilbestrol, diethylstilbestrol diphosphate, nilutamide

Genetic Tests for Cervix Uteri Carcinoma in Situ

Anatomical Context for Cervix Uteri Carcinoma in Situ

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to cervix uteri carcinoma in situ:

22
Cervix

Phenotypes for genes affiliated with Cervix Uteri Carcinoma in Situ

Publications for genes affiliated with Cervix Uteri Carcinoma in Situ

Expression for genes affiliated with Cervix Uteri Carcinoma in Situ

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Cervix Uteri Carcinoma in Situ

Pathways for genes affiliated with Cervix Uteri Carcinoma in Situ

Sources:
34PharmGKB, 37R&D Systems
See all sources

Pathways related to cervix uteri carcinoma in situ according to GeneDecks:

idPathwayScoreTop Affiliating Genes
1Platelet Aggregation Inhibitor Pathway, Pharmacodynamics349.3GP5, GP6
2Blood Coagulation Signaling Pathways379.0GP5, GP6

Compounds for genes affiliated with Cervix Uteri Carcinoma in Situ

GO Terms for genes affiliated with Cervix Uteri Carcinoma in Situ

Sources:
12Gene Ontology
See all sources

Molecular functions related to cervix uteri carcinoma in situ according to GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1collagen bindingGO:0055189.3GP5, GP6

Sources for Cervix Uteri Carcinoma in Situ

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS